3D Systems (NYSE:DDD) announced that two of its Bespoke design applications have been awarded by the 2014 International Design Excellence Awards (IDEA) from the IDSA and Core77. Both the 3D printed personal Ekso robotic exoskeleton and Bespoke Braces for hand and wrist were recognized, with the Ekso being awarded Bronze in the Social Impact category. 3D Systems Corporation (NYSE:DDD) net profit margin is 7.70% and weekly performance is 8.21%. On last trading day company shares ended up $62.24. Analysts mean target price for the company is $65.21. 3D Systems Corporation (NYSE:DDD) distance from 50-day simple moving average (SMA50) is 21.00%.
Nestle SA (NESN) plans to make Coffee-Mate branded capsules that are compatible with Keurig Keurig Green Mountain Inc (NASDAQ:GMCR) machines in the U.S., bringing the world’s biggest coffee maker onto a rival’s system. Keurig Green Mountain Inc (NASDAQ:GMCR) shares fell -1.06% in last trading session and ended the day on $124.15. GMCR Gross Margin is 37.90% and its return on assets is 14.10%. Keurig Green Mountain Inc (NASDAQ:GMCR) quarterly performance is 13.85%.
VW announces a “take over” of the BlackBerry Ltd (NASDAQ:BBRY) Connectivity Research Centre. It seems BlackBerry is parting ways with 200 employees as part of the deal.BlackBerry Ltd (NASDAQ:BBRY) shares moved up 1.33% in last trading session and was closed at $10.66, while trading in range of $10.61-$10.88. BlackBerry Ltd (NASDAQ:BBRY) year to date performance is 43.28%.
Lululemon Athletica inc. (NASDAQ:LULU) was downgraded by equities researchers at JPMorgan Chase & Co. from an “overweight” rating to a “neutral” rating in a research report issued on Friday. They currently have a $42.00 price objective on the stock. Lululemon Athletica inc. (NASDAQ:LULU) ended the last trading day at $41.10. Company weekly volatility is calculated as 2.59% and price to cash ratio as 8.01. Lululemon Athletica inc. (NASDAQ:LULU) showed a positive weekly performance of 0.68%.
0n June 27,2014 EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced that the U.S. Food and Drug Administration (FDA) concluded its routine inspection of EDAP’s manufacturing site with no findings nor issuance of Form 483 observations.Marc Oczachowski, EDAP’s Chief Executive Officer, commented, “This is another important step in the FDA PMA process for our Ablatherm-HIFU technology. It confirms and validates EDAP’s ability to comply with high engineering, manufacturing and quality standards. In parallel, our team remains fully focused on preparing for the July 30, 2014 advisory committee meeting.EDAP TMS S.A. (ADR) (NASDAQ:EDAP) net profit margin is -1.40% and weekly performance is 35.66%. On last trading day company shares ended up $5.82. Analysts mean target price for the company is $6.00. EDAP TMS S.A. (ADR) (NASDAQ:EDAP) distance from 50-day simple moving average is 62.43%.